In recognition of National Obesity Awareness Week, we partnered with thought leaders across the NHS, civil society and life sciences to discuss obesity and improvement to care pathways.
Project Director at NHS Horizons, Sasha Karakusevic writes about how we can design an active future following the publication of their latest report.
As part of the innovating healthcare strategy, Professor Mike Bewick, Former Deputy National Medical Doctor at NHS England, sits down with Sasha Karakusevic at NHS Horizons, Steve Mann, Director at 4Global and Lord James Bethell, Former Minister for the Innovation Department of Health and Social Care to discuss the UK’s obesity roadmap.
The Government has faced backlash against its failing effort to tackle obesity across the UK. Jamie Oliver has joined criticism of the U-turn on fast food policy, refusing the government’s excuse of the current cost-of-living crisis.
As the Government cuts the £100 million weight management service to help those living with obesity to lose weight, Dolly Theis writes why this decision is politically misjudged.
A story of creativity – and why our national renewal depends upon it.
Deputy Mayor for Children and Families in London, Joanne McCartney, sets out why universal free school meal schemes are the way forward to address food insecurity, improve health and education outcomes for children and build a brighter future for young people.
Lucy Frazer, Secretary of State for Culture, Media, and Sport, discusses the power of UK sport, with particular emphasis on the rise of women’s involvement.
In a compelling address at Chamber and IQVIA’S Midlands Seminar, Preet Kaur Gill, Shadow Minister for Primary Care and Public Health, outlined the party’s vision for enhancing health outcomes in the region.
The Government is set to introduce a groundbreaking legislation that will prohibit the sale of cigarettes in England to individuals who are 14 years old or younger as of this year. This move is part of an effort to pave the way for what is being termed as the first ‘smoke-free generation.’
Eli Lilly’s diabetes drug Mounjaro has gained the backing of Britain’s healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly controlled type 2 diabetes. The National Institute for Health and Care Excellence (NICE) said in draft final guidance that it estimates some 180,000 people could benefit from the new treatment.
Russell George MS discusses Welsh devolution and criticises the Labour Party’s management of NHS Wales.
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
